AlzChem Group AG

Alzchem Group AG adopted a comprehensive investment program of around EUR 120 million for further capacity expansion in creatine products. The investment will go into a new, increasingly automated production facility for creatine and its precursors, as well as upstream infrastructure, with commissioning planned in stages starting in the second half of 2027.

Alzchem Group AG plans to significantly increase its production capacity for nitroguanidine in Trostberg, Germany, with a total investment of approximately EUR 152 million. The new production capacities are expected to be commissioned in the second half of 2026.

AlzChem Group AG is expanding its nitrile production capacity by up to 50% at its Trostberg site, with an investment of approximately EUR 12 million. The expansion is expected to be completed by the second quarter of 2021.